We back clinically validated MedTech companies at the point where execution and commercialization determine outcomes.
Strategic Operating Platform
Exclusive U.S. commercialization platform for advanced medical diagnostic products, serving over 200 clinical laboratories nationwide with rapid turnaround capabilities.
Operating
Exclusive U.S. commercialization platform for advanced medical diagnostic products, serving over 200 clinical laboratories nationwide with rapid turnaround capabilities.
Revenue: $12M+ ARR
ICHORtec GmbH , Innovative Molecular Diagnostics & Chemical Sensors
Our patented technologies support research, industrial applications, and environmental monitoring with pioneering Point-of-Need solutions.
We focus on developing a platform for rapid molecular pathogen detection—including viruses, bacteria, and circulating tumor DNA—using our quantum physics–based Fluorimetry of Molecular Binding (FMB®) technique. This enables direct detection of nucleic acids (ssRNA, dsDNA), ensuring high diagnostic sensitivity and specificity
Next-Generation Cardiac Diagnostics
EKGx is a portable, stickerless 12-lead EKG platform designed to modernize cardiac diagnostics across a wide range of care environments. The system combines FDA-cleared hardware with a digital-first software platform to deliver fast, accurate exams with seamless EMR and EHR integration.
By eliminating shaving, gels, and adhesive electrodes, EKGx improves workflow efficiency, diagnostic consistency, and patient comfort while enabling scalable deployment across acute, post-acute, outpatient, and decentralized care settings.
Unified Enterprise Medical Imaging
NXXIM is an enterprise imaging platform that unifies medical imaging across all specialties into a single-pane clinical viewer. The platform integrates seamlessly with existing PACS and EHR systems, enabling faster collaboration, reduced IT complexity, and real-time access to imaging data across care teams.
Built on a cloud-native architecture with AI-enabled analytics, NXXIM streamlines imaging workflows, reduces diagnostic delays, and delivers measurable operational and cost efficiencies for hospitals and large healthcare systems.
For MedTech companies approaching scale and investors seeking meaningful impact and significant returns.
Post-Clinical Advantage
Commercialization Engine
